XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Shapiro, MD
Barrow Neurological Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Queen Elizabeth Ii Health Sciences Center
Halifax, Nova Scotia, Canada
- Kingston General Hospital
Kingston, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Sunnybrook and Women'S College Health
Toronto, Ontario, Canada
- Barrow Neurological Institute
Phoenix, Arizona, United States
- Ucsf Fresno Center for Clinical Studies
Fresno, California, United States
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Uc Davis Medical Center, Division of Medical Oncology
Sacramento, California, United States
- Uc San Diego, Thornton Hospital
San Diego, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Colorado Neurological Institute
Englewood, Colorado, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Cancer Institute of Orlando
Orlando, Florida, United States
- Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States
- Evanston Northwestern Healthcare
Evanston, Illinois, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Hermelin Brain Tumor Center, Henry Ford Hospital
Detroit, Michigan, United States
- Neurology Group of Bergen County
Ridgewood, New Jersey, United States
- Dent Neurologic Institute
Amherst, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Good Samaritan Hospital
Cincinnati, Ohio, United States
- University Hematology Oncology Care, Llc
Cincinnati, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Oregon Clinic
Portland, Oregon, United States
- Virginia Mason Clinic
Seattle, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2004
- Primary completion
- 31 Mar 2008
- Completion
- 31 Mar 2008
- Last update posted
- 13 Aug 2014
- Registered enrollment
- 200
- Registry id
- NCT00088166
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.